Cargando...
Treatment of Cystic Fibrosis: From Gene- to Cell-Based Therapies
Prognosis of patients with cystic fibrosis (CF) varies extensively despite recent advances in targeted therapies that improve CF transmembrane conductance regulator (CFTR) function. Despite being a multi-organ disease, extensive lung tissue destruction remains the major cause of morbidity and mortal...
Guardado en:
| Publicado en: | Front Pharmacol |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8007963/ https://ncbi.nlm.nih.gov/pubmed/33796025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.639475 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|